Discover the Power
of ACROSS Partnerships

Partner with us to access global innovation, leverage local expertise, and collaborate with industry leaders to accelerate clinical research and achieve impactful results together.

Explore Our Global
Network of Trusted Partners

ACROSS Global Alliance brings together a diverse network of leading clinical research organizations and industry experts. Explore our trusted partners who contribute to advancing innovation and excellence in clinical research worldwide.

Global CRO Coverage

Global CRO Coverage - Activa

Discover More

Global CRO Coverage - Balsam_CR

Discover More

Global CRO Coverage - GLSA

Discover More

Global CRO Coverage - Guosa Life Sciences

Discover More

Global CRO Coverage - Phoenix Clinical Research

Discover More

Global CRO Coverage - Research Professionals

Discover More

Specialist Service Providers (SSPs)

Specialist Service Provider - ConsilX

Discover More

Specialist Service Provider - IRM

Discover More

Specialist Service Provider - Wemedoo

Discover More

Executive Committee Members

Alliance Model Benefits

Why Engage With Us?

ACROSS Global Alliance offers a proven framework for collaboration, empowering clinical research companies to expand their reach, optimize operations, and achieve exceptional outcomes. Discover the key benefits of our global network.

Across Global Alliance - Infographic_2

Efficiently Managing Clinical Trials from Start to Finish

Real-Time Impact:
How the Alliance Delivers Results

Rapid Proposals

Generate tailored project proposals quickly with our advanced technology. Streamline planning and execution to support your clinical trial goals efficiently, ensuring timely delivery and helping your projects stay on schedule.

Accelerated Recruitment

Reach diverse demographics quickly with our expansive global network. Our tailored recruitment strategies ensure optimal participant enrollment, reducing timelines and supporting the success of your clinical trials.

Proven Efficiency

Streamline your clinical trials with an integrated approach that eliminates the need for third-party systems. Seamless connections to external tools ensure real-time data flow, enhancing accuracy, reducing delays, and driving operational excellence.

Partner With Us
to Advance Clinical Research

Connect with us today to explore how we can help bring your innovative research to life

ACTIVA

ACTIVA CRO is a full-service expert Contract Research Organization (CRO) with operations in Latin America, who provides the CRO, Biotech, Pharmaceutical, and Medical Device Industry with a range of services related to the clinical development of healthcare products and solutions.

ACTIVA CRO brings today a vast number of projects-experience in all Clinical trial phases and major therapeutic indications, including Oncology, Hematology, Cardiovascular, Orphan Diseases, CNS, First in Human, and Pivotal studies in Medical Devices, with senior project managers that bring an average of 10 years of experience gained in CROs and Pharmaceutical companies.

ACTIVA CRO considers itself an expert Pharma, Biotech, and Medical Device CRO company, offering personalized high quality clinical research services.

We endeavor to satisfy our clients & partners requirements and expectations by working closely with them to facilitate the efficient management of their projects and the success is traduced to establish long strong relationships with our business partnerships.

Balsam

Balsam Clinical Research, founded in 2021 in Saudi Arabia, is a full-service Contract Research Organization (CRO) accredited by the Saudi FDA.

They offer comprehensive services, including medical writing, biostatistics, project management, clinical operations, and regulatory support, tailored to the unique needs of the Middle East and North Africa (MENA) region.

Renowned for their quality deliverables, Balsam CR aims to bring Swiss standards to Middle Eastern clinical research.

Their commitment to transparency, quality, commitment, and efficiency has established them as a trusted partner in advancing healthcare innovations across the region.

Global Life Sciences Alliance | GLSA

Global Life Sciences Alliance (GLSA) is a dynamic network of global Contract Research Organizations (CROs) and clinical research vendors dedicated to providing innovative clinical trial solutions for Sponsors and CROs.

With over 100 years of combined experience, GLSA offers comprehensive services, including vendor selection and oversight, patient recruitment and retention, and site contracts and negotiations.

Their global reach and collaborative approach ensure tailored solutions that accelerate clinical trial timelines and enhance research quality.

By connecting sponsors with the right CROs, GLSA propels clinical trials into the future, fostering partnerships that drive value and success.

Guosa Life Sciences

Guosa Life Sciences (GLS) is a specialty Contract Research Organization (CRO) with a strong presence in both the United States and Sub-Saharan Africa.

They offer comprehensive drug development lifecycle management solutions to pharmaceutical, biotechnology, medical device, academic, government, and non-governmental organizations.

With regional offices in the U.S., Kenya, Ghana, and Nigeria, GLS is adept at navigating the complexities of both developed and emerging markets.

Their commitment to patient safety, quality, and cost-effective services makes them a trusted partner in advancing global healthcare initiatives.

Phoenix Clinical Research

Phoenix Clinical Research (Phoenix CR), headquartered in Beirut, Lebanon, with Offices in Saudi Arabia, United Arab Emirates, Egypt and Tunisia, is a dynamic full-service Contract Research Organization (CRO) dedicated to advancing clinical research across the Middle East and North Africa (MENA) region.

With over 21 years of international and regional expertise, Phoenix CR offers comprehensive services including clinical operations, medical writing, biostatistics, project management, and pharmacovigilance.

Their commitment to transparency, quality, commitment, and efficiency ensures top-tier results tailored to each client’s unique needs.

As an ISO-accredited organization, Phoenix CR upholds the highest standards, making them a trusted partner for pharmaceutical and biotechnology companies aiming to conduct clinical trials in the MENA region.

Research Professionals

Research Professionals CRO (RP-CRO), headquartered in Budapest, Hungary, is a leading Good Clinical Practice (GCP) compliant Contract Research Organization (CRO) with operations extending across Poland, Czechia, Romania, Bulgaria, and Serbia.

Specializing in comprehensive clinical research management services, RP-CRO leverages an extensive network of experienced Principal Investigators (PIs) and large local subject pools to accelerate study enrollment across diverse therapeutic areas.

Their commitment to quality is underscored by robust quality systems adhering to GCP regulations and a CenterWatch-based Quality Management System (QMS), ensuring high-quality clinical trial submissions to global regulatory bodies, including the U.S. FDA and EMA.

As the founder of ACROSS Global™, a strategic alliance of CROs covering 99 countries, RP-CRO offers clients access to more than 8,835 study sites worldwide, exemplifying their dedication to efficient, flexible, and high-quality clinical research solutions.

ConsilX

Consilx Digital, a technology platform provider for clinical trials strive to optimize the long, expensive clinical trial processes to improve efficiency and effectiveness, and enabling next generation trials, including virtual/digital trials.

Consilx’s platforms (eConsent, patient engagement, EDC, Direct data capture, and Telemedicine), digitize critical aspects of drug development, connect patients with clinical site personnel, facilitate tele-conduct and remote data collection from variable sources such as wearables, devices, PROs, etc.

IRM Europe

IRM supports all stakeholders in clinical research, including patients, clinical sites, CROs, Sponsors, and global Functional Service Providers, with a focus on achieving successful and timely project delivery.

Their expertise spans patient travel and transportation, sourcing and rental of medical equipment and ancillary materials, establishing clinical trial referral networks for patient recruitment, importer of record (IoR) services, and strategic consulting.

At IRM , we are dedicated to delivering tailored solutions that streamline clinical research operations, ensuring efficiency and excellence at every stage of the project lifecycle.

Wemedoo

Wemedoo AG is a Swiss company at the forefront of medical innovation, seamlessly merging clinical practice and research through the integration and standardization of clinical data. Our AI-powered solutions streamline clinical data management through interoperability, ensuring efficiency, compliance, and seamless collaboration between CROs, sponsors, and research teams.

With a centralized infrastructure, Wemedoo eliminates data silos, reduces manual work, and accelerates trial timelines while maintaining regulatory excellence. We empower CROs to work smarter, not harder, by providing real-time insights, automated workflows, and risk-based monitoring to enhance trial efficiency.

At Wemedoo, we don’t just provide solutions – we help CROs build trust with sponsors, optimize trial execution, and succeed in an increasingly complex research landscape

Steven Bukvic

Steven Bukvic graduated from Coventry University in 1982 with a degree in Applied Biology. After serving in the commercial sector of the UK motor industry for 8 years, Steven joined the Pharmaceutical Industry in 1990. For the next 27 years Steven’s career in the Pharmaceutical / CRO sectors has covered a broad range of disciplines within the field of clinical research, including clinical site monitoring, project management, pharmacovigilance, training, quality assurance and business operations. Steven has worked in Covance, GSK, MSD and Pfizer to name just a few of the multi-national companies in his career. Steven was instrumental in establishing a CRO in Asia as well as successfully building a number of CRO partnerships. He has also had extensive geographical exposure having worked in the UK, US, Germany, China and the Russian Federation.

Dr. Jawad Gill

Dr Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Dr Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Eventually he moved on to GSK Singapore as Clinical Research, Quality and Training Manager, where he managed teams across Asia-Pacific, Middle East, Africa, and Central Asian regions. During this time, he developed, trained, and led Clinical Operations country teams in Singapore, Malaysia, and Vietnam.

In his most recent role at Fortrea (previously known as Covance) Singapore, as Head of Clinical QA&C he managed Southeast Asia, Japan, South Korea, Australia, and New Zealand, leading a team of auditors conducting Investigator Site Audits, Process Audits, Vendor Qualification Audits, and supporting Client Audits and Regulatory Inspections.

Dr Gill has held leadership positions in various functions, organizations, and regions and has developed, trained, and led several teams simultaneously. Overall, he has been actively involved in more than 150 clinical studies with different phases, designs, and complexities. He has conducted trainings for clinical research professionals and investigators in Pakistan, China, Taiwan, Philippines, S. Korea, S. Africa, Thailand, Vietnam, Turkey and several other countries. He has been involved in the formulation of clinical research guidelines and regulations in some developing countries.

Denise McNerney

With over 25 years of expertise in Business, Marketing, and Technology within the life sciences industry, Denise is a seasoned professional. Her entrepreneurial drive, coupled with vast knowledge and resources, has fueled the creation of multiple successful businesses, streamlined processes, and fostered cohesive teams. Throughout her career, Denise has been instrumental in the launch of innovative products and services, effectively reaching targeted audiences. Building on a foundation of trust, she has cultivated enduring business relationships.

As a Partner at Global Life Sciences Alliance, Denise channels her skills into business development, strategy, and operations. Beyond her professional endeavors, Denise finds joy in volunteering for nonprofits, mentoring individuals and advising startup companies. An avid traveler and enthusiast of an active lifestyle, she embraces diverse experiences in both her personal and professional spheres.

Charles Oviawe

Charles is a Quality Assurance professional with over 20 year’s experience in Quality Systems Development and Management with emphasis on the United States Food and Drug Administration, ICH and global requirements for Good Clinical Practices, Good Laboratory Practice for Nonclinical Laboratory Studies, Good Pharmacovigilance Practices, Clinical Laboratory Improvement Amendments, current Good Manufacturing Practices and Computer System Validation.

Georges Labaki

Georges Labaki obtained his Pharm D in 2000 from Saint Joseph University in Lebanon. In addition, he holds a Master’s Degree in Cardiovascular Pharmacology from Claude-Bernard University, Lyon, France and an executive MBA from Ecole Supérieure des Affaires, Lebanon. Dr Labaki developed 18 years of professional experience in clinical research from big pharmaceutical companies and CROs in Lebanon and Switzerland, such as Merck Serono, Sanofi, Quintiles Outcome and ClinTec International.

Starting October 2012, Dr Labaki became the Chief Executive Officer of his own Clinical Research Organization (CRO): Phoenix Clinical Research (Phoenix CR); with main focus on the Middle East and North Africa region.

He is also the Co-Founder of Balsam Clinical Research, that started operations in Saudi Arabia in October 2021.

Kálmán Törőcsik

Kálmán Törőcsik graduated from University of Szeged in 2005 as doctor of medicine. Since his graduation Kálmán serves the Pharmaceutical Industry. Working with different Pharmaceutical and CRO companies like Amgen, Allergan, Pfizer and Chiltern Kalman collected experience on several fields of clinical research operation as CRA and project manager. Starting March 2014, as a joint partner, Kalman became the Chief Operating Officer of Research Professionals Ltd., a Hungarian CRO with main focus on Central European Region. In this position his is responsible for conducting of clinical trials and home care services in the region.

Mariano Monteagudo

With over 14 years of experience in pharmacology and clinical research, he currently leads the business development and customer relations efforts at Activa-CRO, focused on finding the best solution for project success from regulatory, operational and financial perspectives. Mr. Monteagudo received both his Pharmacist and MBA at Pontificia Universidad Catòlica (UCA) Buenos Aires, ARG, and has held a range of positions of increasing responsibility in the CRO industry, including experience in Quintiles, Merck Sharpe & Dohme Laboratory (MSD), GSK Pharmaceutical, MDS Pharma Services, MDS Pharma Services, INC Research and I3. Joining Activa in 2013, he worked as CTM as well as interacting with clinical operation planning and customer relations with Biotechs, Pharmaceutical company and CROS and his new position since 2015 as Director Business Development Strategy in which he acts as primary contact of client from US, Europe and Asia due in order to develop and stablish a project in the following Latin America countries: Argentina, Chile, Uruguay, Brazil, Peru, Colombia, Panama, Ecuador and Mexico.

Nikola Cihoric

Nikola is the founder and the innovative mind behind Wemedoo AG.

With over 15 years of experience in radiation oncology at Switzerland’s largest university hospital, he has garnered a reputation as a visionary in the industry. Nikola’s involvement in various international working groups, such as mCODE, CodeX, HL7/FHIR, CDISC, and DIA Europe, reflects his dedication to advancing clinical data standards, driving innovation, and ensuring the highest quality of clinical data management.

Nikola holds an M.D. in medicine from the University of Belgrade, Serbia, with a specialization in radiation oncology from the University of Berne, Switzerland.